Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
| Image |  |
|---|---|
| Description | scientific article published on 01 December 2020 |
| Author/s |
author: Martha Wadleigh Talha Badar Ibrahim Aldoss Nikolai Podoltsev Mark R Litzow Anand A Patel Mehrdad Hefazi |
| Publication date | December 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |